NTRK2 and glioblastoma: Contrary to existing hypotheses surrounding the full-length kinase, TrkB.FL, as the sole suspected NTRK2 contribution to oncogenesis, TrKB.FL levels remain relatively consistent across pooled normal supratentorial regions, LGG and GBM (Fig. 2a, Table 2, Supplementary Data 2).